HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
263 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-11 (jdsupra.com)
ANDA Litigation Settlements - Winter 2024 | Robins Kaplan LLP - JDSupra
This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that...
Read more
2024-06-18 (drugwatch.com)
Valsartan Lawsuit Settlement Nears for Hetero, But Fight Continues for Others
While valsartan lawsuits near settlement for some, Judge Bumb pushes for talks in losartan contamination cases. Less than 5% of cases are impacted by the current deal. Learn more about ongoing litigation.
Read more
2023-04-03 (indiatimes.com)
Supreme Court junks Hetero plea to quash quid pro quo case
The Supreme Court on Friday dismissed the pleas of pharmaceutical firm Hetero and its director M Srinivas Reddy to quash the CBI case filed against th
Read more
2022-01-06 (thewire.in)
The Zydus Cadila Remdesivir Fiasco Wasn’t an Isolated Incident – The Wire Science
Discussions with regulators and procurers suggest these agencies may have ignored many similar incidents during India's COVID-19 epidemic.
Read more
(legalserviceindia.com)
A Landmark Case: Analyzing Sun Pharmaceutical Laboratories Ltd v/s Hetero Healthcare Ltd
Facts of the Case: Sun Pharmaceutical Laboratories Ltd. (SUN) filed a suit against Hetero Healthcare Ltd. (HETERO), alleging trademark infringement and passing off. SUN claimed to be one of th...
Read more